Mendaera
PrivateLast Round
Series B
Sep 26, 2024
Total Funding Raised
$97M
Momentum
Top 25%
of companies Caplight tracks
Company Overview
Mendaera is a healthcare technology company that develops a handheld robotic platform integrating real-time imaging, artificial intelligence, and connectivity to enhance the precision and consistency of needle-based medical procedures.
Sector
Healthcare & Life Sciences
Verticals
Medical Devices, Medical Imaging, Industrial Robotics
Business Model
B2B
Customer Profile
Hardware Sales, Revenue Share
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Mendaera Comparables
Compare Mendaera with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Obvius Robotics, Inc. | 83% | |
| Interventional Systems | 82% | |
| Perfint Healthcare | 74% | |
Mendaera Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series B | Sep 26, 2024 | ||||
| Series A | Aug 17, 2023 |
Key People
Founding team and executive leadership
Mendaera Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Threshold Ventures | Series B |
| Parade Ventures | Series A |
| Puma Venture Capital | Series B |
| Allen & Company | Series A |
| Founders Fund | Series A |
| Lux Capital | Series B, Series A |
| PFM Health Sciences | Series B |
Market signals
Structured signals derived from secondary market and firmographic data.
- May 12, 2026
Launched Focalist, an image-guided intervention platform.
- Jan 8, 2025
Eric Davidson appointed as the first Chief Commercial Officer.
Mendaera Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Mendaera's valuation, stock price, and market status.